In AMCP's latest comments to the FDA, we emphasize the need for standardized public reporting of confirmatory trial progress, ensuring payers and health care providers have the necessary data to make informed coverage decisions. By supporting proactive communication and rigorous confirmatory trials, AMCP aims to balance early access to innovative treatments with patient safety and long-term therapeutic value.

Over the weekend, Congressional leadership released a continuing resolution (CR) that extends government funding at the same level as the previous fiscal year, through September 30. Congress must extend government funding by March 14 to avoid a government shutdown.

The Emerging Trends in Managed Care Pharmacy report is part of a larger AMCP Foundation initiative to facilitate deep discussions between health care stakeholders about managed care emerging trends, with a focus on providing opportunities to collaborate on solutions.

This year, there may be two or more overlapping budget packages likely to contain some of the most significant legislation of 2025. AMCP’s Adam Colborn analyzes how these bills are different and what they mean for managed care and health care broadly. Read more: